探索心血管不良事件和抗抑郁药使用之间的相关性:基于FDA不良事件报告系统数据库的回顾性药监测分析
Zhanzhang Wang1, Haoyang Lu1, Yuandan Li2
1The Affiliated Brain Hospital, Guangzhou Medical University, 36 Mingxin Road, Guangzhou 510370, China; Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, Guangzhou Medical University, Guangzhou 510370, China.
Journal of affective disorders
|August 29, 2024
概括
抗抑郁药的使用与心血管不良事件有关,特定的药物类别和神经递质相互作用增加了风险. 需要进一步的研究来证实这些发现,并指导更安全的处方实践.
科学领域:
- 药物监督 药物监督 药物监督
- 心血管药理学心血管药理学
- 心理药理学 心理药理学
背景情况:
- 抑郁症和心血管疾病之间的高并发症引起了人们对抗抑郁药物心血管风险的担忧.
- 进行了与37种抗抑郁药物相关的心血管不良事件 (AE) 的综合评估.
研究的目的:
- 评估与常用抗抑郁药物相关的心血管性副作用的类型和程度.
- 探索抗抑郁药相关心血管风险的潜在机制.
主要方法:
- 从FDA不良事件报告系统 (FAERS) 数据库 (2004-2023) 获取AE报告.
- 使用不成比例分析 (报告概率比率,比例报告比率,信息组件) 来识别心血管信号.
- 探索了影响心血管死亡的因素和潜在的神经递质机制.
主要成果:
- 抗抑郁药的使用与八种类型的心血管事件有关.
- 单胺氧化酶抑制剂显示出六种心血管事件类别的最高风险,包括TdP/QT延长和高血压.
- 阿莫克萨和莫克洛贝米德具有最高的相关风险;药物向相互作用 (多巴胺,北上腺素载体) 与TdP/QT延长,高血压和心肌病相关.
结论:
- 心血管性AE与抗抑郁药的使用有关,受神经递质结合/吸收抑制和选择性的影响.
- 这些发现为进一步研究抗抑郁药相关心血管毒性的研究提供了基础.
- 建议进行前性研究以验证这些探索性发现.
相关概念视频
Pharmacovigilance
789
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
789
Antidepressant Drugs: Overview
389
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
389
Antidepressant Drugs: MAOIs and Other Agents
205
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
205
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
335
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
335
Assessment of the Cardiovascular System I: Subjective Data
291
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
291
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.1K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.1K


